Puma Biotechnology Statistics
Total Valuation
PBYI has a market cap or net worth of $538.91 million. The enterprise value is $449.83 million.
| Market Cap | 538.91M |
| Enterprise Value | 449.83M |
Important Dates
The next confirmed earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBYI has 51.62 million shares outstanding. The number of shares has increased by 3.62% in one year.
| Current Share Class | 51.62M |
| Shares Outstanding | 51.62M |
| Shares Change (YoY) | +3.62% |
| Shares Change (QoQ) | +3.44% |
| Owned by Insiders (%) | 13.84% |
| Owned by Institutions (%) | 67.69% |
| Float | 40.34M |
Valuation Ratios
The trailing PE ratio is 20.73.
| PE Ratio | 20.73 |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| Forward PS | 4.32 |
| PB Ratio | 3.85 |
| P/TBV Ratio | 5.28 |
| P/FCF Ratio | 13.09 |
| P/OCF Ratio | 13.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.21, with an EV/FCF ratio of 10.93.
| EV / Earnings | 16.84 |
| EV / Sales | 1.95 |
| EV / EBITDA | 11.21 |
| EV / EBIT | 14.78 |
| EV / FCF | 10.93 |
Financial Position
The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.91 |
| Quick Ratio | 2.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.12 |
| Interest Coverage | 8.65 |
Financial Efficiency
Return on equity (ROE) is 21.97% and return on invested capital (ROIC) is 56.55%.
| Return on Equity (ROE) | 21.97% |
| Return on Assets (ROA) | 9.81% |
| Return on Invested Capital (ROIC) | 56.55% |
| Return on Capital Employed (ROCE) | 21.30% |
| Weighted Average Cost of Capital (WACC) | 11.36% |
| Revenue Per Employee | $1.29M |
| Profits Per Employee | $149,263 |
| Employee Count | 179 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 5.31 |
Taxes
In the past 12 months, PBYI has paid $4.45 million in taxes.
| Income Tax | 4.45M |
| Effective Tax Rate | 14.28% |
Stock Price Statistics
The stock price has increased by +102.33% in the last 52 weeks. The beta is 1.21, so PBYI's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +102.33% |
| 50-Day Moving Average | 9.82 |
| 200-Day Moving Average | 7.91 |
| Relative Strength Index (RSI) | 52.91 |
| Average Volume (20 Days) | 354,020 |
Short Selling Information
The latest short interest is 4.54 million, so 8.80% of the outstanding shares have been sold short.
| Short Interest | 4.54M |
| Short Previous Month | 4.26M |
| Short % of Shares Out | 8.80% |
| Short % of Float | 11.25% |
| Short Ratio (days to cover) | 13.75 |
Income Statement
In the last 12 months, PBYI had revenue of $231.24 million and earned $26.72 million in profits. Earnings per share was $0.50.
| Revenue | 231.24M |
| Gross Profit | 173.05M |
| Operating Income | 30.44M |
| Pretax Income | 31.17M |
| Net Income | 26.72M |
| EBITDA | 40.12M |
| EBIT | 30.44M |
| Earnings Per Share (EPS) | $0.50 |
Balance Sheet
The company has $93.90 million in cash and $4.82 million in debt, with a net cash position of $89.09 million or $1.73 per share.
| Cash & Cash Equivalents | 93.90M |
| Total Debt | 4.82M |
| Net Cash | 89.09M |
| Net Cash Per Share | $1.73 |
| Equity (Book Value) | 138.54M |
| Book Value Per Share | 2.71 |
| Working Capital | 95.25M |
Cash Flow
In the last 12 months, operating cash flow was $41.15 million and capital expenditures $10,000, giving a free cash flow of $41.16 million.
| Operating Cash Flow | 41.15M |
| Capital Expenditures | 10,000 |
| Depreciation & Amortization | 9.68M |
| Net Borrowing | -44.45M |
| Free Cash Flow | 41.16M |
| FCF Per Share | $0.80 |
Margins
Gross margin is 74.83%, with operating and profit margins of 13.16% and 11.55%.
| Gross Margin | 74.83% |
| Operating Margin | 13.16% |
| Pretax Margin | 13.48% |
| Profit Margin | 11.55% |
| EBITDA Margin | 17.35% |
| EBIT Margin | 13.16% |
| FCF Margin | 17.80% |
Dividends & Yields
PBYI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.62% |
| Shareholder Yield | -3.62% |
| Earnings Yield | 4.82% |
| FCF Yield | 7.64% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 0.24% |
| EPS Growth Forecast (3Y) | -26.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PBYI has an Altman Z-Score of -3.73 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.73 |
| Piotroski F-Score | 7 |